Response inhibition predicts poor antidepressant treatment response in very old depressed patients

American Journal of Geriatric Psychiatry

Volumn 15, Issue 7, 2007, Pages 553-563

  Sneed, Joel R ^a   Roose, Steven P ^b   Keilp, John G ^b   Krishnan, K Ranga Rama ^c   Alexopoulos, George S ^b   Sackeim, Harold A ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cerebrovascular Disease; Executive dysfunction; Geriatric depression; Treatment outcome; Vascular depression, late onset depression

Indexed keywords

CITALOPRAM; PLACEBO; ANTIDEPRESSANT AGENT; SERTRALINE;

AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PREDICTION; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE; STROOP COLOR WORD TEST; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TREATMENT OUTCOME; TREATMENT RESPONSE; VERY ELDERLY; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; DRUG RESISTANCE; PSYCHOLOGICAL ASPECT;

AGE OF ONSET; AGED; ANTIDEPRESSIVE AGENTS; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; FEMALE; HUMANS; MALE; SERTRALINE; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 34548073674     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3180302513     Document Type: Article

References (43)

1. Hickie I, Scott E, Mitchell P, et al: Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 1995; 37:151-160
2. Krishnan KR, Hays JC, Blazer DG: MRI-defined vascular depression. Am J Psychiatry 1997; 154:497-501
3. Salloway S, Malloy P, Kohn R, et al: MRI and neuropsychological differences in early- and late-life-onset geriatric depression. Neurology 1996; 46:1567-1574
4. Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Silbersweig D, Charlson M: Clinically defined vascular depression. Am J Psychiatry 1997; 154:562-565
5. Lesser I, Boone K, Mehringer C, Wohl M, Miller B, Berman N: Cognition and white matter hyperintensities in older depressed patients. Am J Psychiatry 1996; 153:1280-1287
6. Podell K, Lovell MR: Neuropsychological assessment, in Textbook of Geriatric Neuropsychiatry. Edited by Coffey CE, Cummings JL. Washington DC, American Psychiatric Press, 2000
7. Simpson S, Baldwin RC, Jackson A, Burns AS: Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological, and neuroradiological findings in late-life depression. Psychol Med 1998; 28:1015-1026
8. Taylor WD, Steffens DC, MacFall JR, et al: White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatry 2003; 60:1090-1096
9. Salloway S, Correia S, Boyle P, et al: MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression. J Neurol Sci 2002; 203:227-233
10. Baldwin R, Jeffries S, Jackson A, et al: Treatment response in late-onset depression: relationship to neuropsychological, neuroradiological and vascular risk factors. Psychol Med 2004; 34:125-136
11. Alexopoulos GS, Meyers BS, Young RC, et al: Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry 2000; 57:285-290
12. Butters MA, Bhalla RK, Mulsant BH, et al: Executive functioning, illness course, and relapse/recurrence in continuation and maintenance treatment of late-life depression. Am J Geriatric Psychiatry 2004; 12:387-394
13. Alexopoulos GS, Meyers BS, Young RC, et al: Recovery in geriatric depression. Arch Gen Psychiatry 1996; 53:305-312
14. Driscoll HC, Basinski J, Mulsant BH, et al: Late-onset major depression: clinical and treatment-response variability. Int J Geriatric Psychiatry 2005; 20:661-667
15. Reynolds CF3rd, Dew MA, Frank E, et al: Effects of age at onset of first lifetime episode of recurrent major depression on treatment response and illness course in elderly patient. Am J Psychiatry 1998; 155:795-799
16. Roose SP, Sackeim HA, Krishnan KRR, et al. Group O-ODS: Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiatry 2004; 161:2050-2059
17. Alexopoulos GS: "The depression-executive dysfunction syndrome of late life": a specific target for D3 agonists? Am J Geriatric Psychiatry 2001; 9:22-29
18. Royall DR, Lauterbach EC, Cumings JL, et al: Executive control function: a review of its promise and challenges for clinical research. J Neuropsychiatry Clin Neurosci 2002; 14:377-405
19. Krishnan KRR, Hays JC, Tupler LA, George LK, Blazer DG: Clinical and phenomenological comparisons of late-onset and early-onset depression. Am J Psychiatry 1995; 152:785-788
20. Steffens DC, Krishnan KR: Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry 1998; 43:705-712
21. Van den Berg MD, Oldehinkel AJ, Bouhuys AL, Brilman EI, Beekman AT, Ormel J: Depression in later life: three etiologically different subgroups. J Affective Disorders 2001; 65:19-26
22. Lezak MD: Neuropsychological Assessment. New York, Oxford University Press, 1995
23. Golden CJ: The Stroop Color and Word Test: A Manual for Clinical and Experimental Use. Wood Dale, Stoelting, 1978
24. Alexopoulos G, Kiosses DN, Murphy CF, Shanmugham B, Gunning-Dixon F. Executive dysfunction and the course of geriatric depression. Biol Psychiatry 2005; 58:204-210
25. Singer JD, Willett JB: Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York, Oxford University Press, 2003
26. Mallinckrodt CH, Kaiser CJ, Watkin JG, Molenberghs G, Carroll RJ: The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward. Clin Trials 2004; 1:477-489
27. Benton AL, Sivan AB, Hamsher KD, Varney N, Spreen O: Contributions to Neuropsychological Assessment. New York, Oxford University Press, 1994
28. Hindmarch I: Relevant psychometric tests for antidepressants and anxiolytics. Int Clin Psychopharmacol 1994; 9:27-33
29. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 1975; 12:189-198
30. Wechsler D: Wechsler Adult Intelligence Scale-III. San Antonio, Psychological Corporation, 1997
31. Buschke H, Fuld PA: Evaluation of storage, retention, and retrieval in disordered memory and learning. Neurology 1974; 24:1019-1025
32. Miller MD, Paradis CF, Houck PR, et al: Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992; 41:237-248
33. Kalayam B, Alexopoulos GS: Prefrontal dysfunction and treatment response in geriatric depression. Arch Gen Psychiatry 1999; 56:713-718
34. Murphy GF, Alexopoulos GS: Attention network dysfunction and treatment of response of geriatric depression. J Clin Exp Neuropsychol 2006; 28:96-100
35. Salthouse TA: The processing-speed theory of adult age differences in cognition. Psychological Rev 1996; 103:403-428
36. Butters MA, Whyte EM, Nebes RD, et al: The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry 2004; 61:587-595
37. Krishnan KR, Taylor WD, McQuoid DR, et al: Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol Psychiatry 2004; 55:390-397
38. Wiener P, Alexopoulos GS, Kakuma T, Meyers BS, Rosenthal E, Chester J: The limits of history-taking in geriatric depression. Am J Geriatric Psychiatry 1997; 5:116-125
39. Alexopoulos G: Depression in the elderly. Lancet 2005; 365:1961-1970
40. Glassman AH, Occ M, Califf RM, et al: Setraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288:701-709
41. Alexopoulos GS, Raue P, Arean P: Problem-solving therapy versus supportive therapy in geriatric major depression with executive dysfunction. Am J Geriatric Psychiatry 2003; 11:46-52
42. Alexopoulos GS, Kiosses DN, Klimstra S, Kalayam B, Bruce ML: Clinical presentation of the "depression-executive dysfunction syndrome" of late life. Am J Geriatric Psychiatry 2002; 10:98-106
43. Sneed JR, Roose SP, Sackeim HA: Vascular depression: a distinct diagnostic entity? Biol Psychiatry 2006; 60:1295-1298